Safety of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data

Article full text The above summary slide and graphical plain language summary represent the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2020.